Clinical Trials Directory

Trials / Completed

CompletedNCT05918354

Development and Evaluation of an Artificial Intelligence Model for the Diagnosis of Aeroallergies

Development and Evaluation of an Artificial Intelligence Model to Support Read Out of Skin Prick Automated Test Results for the Diagnosis of Aeroallergies

Status
Completed
Phase
Study type
Observational
Enrollment
993 (actual)
Sponsor
Hippocreates · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To improve accuracy and take out human error, Hippo Dx previously developed S.P.A.T., an automated skin prick test. Now, Hippo Dx will develop and evaluate a S.P.A.T. artificial intelligence (AI) medical software to support physicians in the read out of the test results from an automated skin prick test. In this study 700 images will be collected to develop the AI model, an additional 200 images will be collected to evaluate performance of the AI model. In a last independent cohort of 100 patients, performance of read-out by the physician will be compared with read out by the physician supported by the S.P.A.T. AI medical software. The primary endpoint is the accuracy of the maximal wheal size measurement by S.P.A.T. AI versus the maximal wheal size measurement by the physician. It is a prospective multicentric study that will include 1000 study participants from different countries.

Conditions

Interventions

TypeNameDescription
DEVICESkin Prick Automated TestDetection of sensitisation to specific allergens via the skin prick automated test.

Timeline

Start date
2023-07-10
Primary completion
2024-09-11
Completion
2024-09-11
First posted
2023-06-26
Last updated
2024-10-16

Locations

6 sites across 2 countries: Belgium, Germany

Source: ClinicalTrials.gov record NCT05918354. Inclusion in this directory is not an endorsement.